Stan V. Smith - 01 Oct 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MAIA	Stock Options	Award	$0	+9,040		$0.000000	9,040	30 Sep 2024	Common Stock	9,040	$2.81	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date.
F2	These securities are benefically owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.